{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:05:18Z","timestamp":1789095918933,"version":"build-2803163510"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Helse Midt-Norge, Felles forskningsutvalg","award":["101274100"],"award-info":[{"award-number":["101274100"]}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st","doi-asserted-by":"crossref","award":["342266"],"award-info":[{"award-number":["342266"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009123","name":"NTNU","doi-asserted-by":"publisher","award":["980001250"],"award-info":[{"award-number":["980001250"]}],"id":[{"id":"10.13039\/100009123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018724","name":"RCN","doi-asserted-by":"publisher","award":["327005"],"award-info":[{"award-number":["327005"]}],"id":[{"id":"10.13039\/100018724","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bulgarian National scientific Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Enteroviruses infect multiple human tissues and cause diseases including meningitis, the common cold, myocarditis, pancreatitis, hepatitis, poliomyelitis, sepsis, type 1 diabetes, hand, foot, and mouth disease. Despite this burden, no antiviral therapy has been approved to date. Progress has been limited by the structural and topical diversity of enteroviruses because many variants are intrinsically insensitive to candidate agents and sensitive strains develop resistance rapidly. Here, we report that the approved anticancer drug vemurafenib inhibited replication of some tested enteroviruses in cell cultures. Passage of echovirus EV1 and coxsackievirus CVB5 for six cycles in cell culture yielded vemurafenib-resistant virus variants harboring mainly missense mutations in the viral 3A and VP1 proteins, underscoring the need for combination therapy. We therefore evaluated cocktails, combining vemurafenib with the VP1 inhibitor pleconaril and the 3C protease inhibitor AG7404. In cell culture, the cocktails suppressed replication of all seven tested enteroviruses. The combination was also effective in human pancreatic, retinal, and brain organoids. In infected mice, the triple regimen reduced viral titers in the pancreas. These findings support multi-stage targeting of the enterovirus life cycle as a promising path toward broadly active therapeutic cocktails.<\/jats:p>","DOI":"10.1093\/narmme\/ugaf046","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:54:58Z","timestamp":1766148898000},"source":"Crossref","is-referenced-by-count":1,"title":["Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication\n                    <i>in vitro<\/i>\n                    and\n                    <i>in vivo<\/i>"],"prefix":"10.1093","volume":"3","author":[{"given":"Erlend","family":"Ravlo","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-482X","authenticated-orcid":false,"given":"Aleksandr","family":"Ianevski","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleria","family":"Wolska","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn-Ove","family":"Schj\u00f8lberg","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]},{"name":"Department of Microbiology, Oslo University Hospital and University of Oslo , 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"C\u00e1mara-Qu\u00edlez","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ine Emilie Olsen","family":"Nordli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Bj\u00f8rnes","family":"S\u00e6ther","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Lysvand","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentyn","family":"Oksenych","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"V\u00e4h\u00e4-Koskela","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine FIMM, Helsinki Institute for Life Science, University of Helsinki , 00014 Helsinki ,","place":["Finland"]},{"name":"Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki , 00014 Helsinki ,","place":["Finland"]},{"name":"iCAN Digital Precision Cancer Medicine Flagship , 00014 Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Vainionp\u00e4\u00e4","sequence":"additional","affiliation":[{"name":"Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki , 00014 Helsinki ,","place":["Finland"]},{"name":"iCAN Digital Precision Cancer Medicine Flagship , 00014 Helsinki ,","place":["Finland"]},{"name":"Department of Surgery, Faculty of Medicine, University of Helsinki and Helsinki University Hospital , 00014 Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[{"name":"Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki , 00014 Helsinki ,","place":["Finland"]},{"name":"iCAN Digital Precision Cancer Medicine Flagship , 00014 Helsinki ,","place":["Finland"]},{"name":"Department of Surgery, Faculty of Medicine, University of Helsinki and Helsinki University Hospital , 00014 Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Smura","sequence":"additional","affiliation":[{"name":"Department of Virology, University of Helsinki , 00014 Helsinki ,","place":["Finland"]},{"name":"HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, University of Helsinki , 00029 Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Vauhkonen","sequence":"additional","affiliation":[{"name":"Department of Virology, University of Helsinki , 00014 Helsinki ,","place":["Finland"]},{"name":"HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, University of Helsinki , 00029 Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2280-3915","authenticated-orcid":false,"given":"Roni","family":"Odai","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science, Lund University , 22100 Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Stoyanova","sequence":"additional","affiliation":[{"name":"The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences , 1113 Sofia ,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeon A","family":"Galabov","sequence":"additional","affiliation":[{"name":"The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences , 1113 Sofia ,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel S","family":"Galabov","sequence":"additional","affiliation":[{"name":"The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences , 1113 Sofia ,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Plevka","sequence":"additional","affiliation":[{"name":"Central European Institute of Technology, Masaryk University , 62500 Brno ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2981-0803","authenticated-orcid":false,"given":"Magloire Pandoua","family":"Nekoua","sequence":"additional","affiliation":[{"name":"Laboratoire de virologie ULR3610, Univ Lille et CHU Lille , 59000 Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Hober","sequence":"additional","affiliation":[{"name":"Laboratoire de virologie ULR3610, Univ Lille et CHU Lille , 59000 Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8759-1170","authenticated-orcid":false,"given":"Magnar","family":"Bj\u00f8r\u00e5s","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]},{"name":"Department of Microbiology, Oslo University Hospital and University of Oslo , 0372 Oslo ,","place":["Norway"]},{"name":"Centre for Embryology and Healthy Development (CRESCO), University of Oslo , Oslo 0373 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7716-6955","authenticated-orcid":false,"given":"Denis E","family":"Kainov","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology , 7028 Trondheim ,","place":["Norway"]},{"name":"Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki , 00014 Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"2026010823414273700_B1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat Rev Micro"},{"key":"2026010823414273700_B2","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","article-title":"Prospective virome analyses in young children at increased genetic risk for type 1 diabetes","volume":"25","author":"Vehik","year":"2019","journal-title":"Nat Med"},{"key":"2026010823414273700_B3","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/microorganisms8101458","article-title":"Enteroviruses and Type 1 Diabetes Mellitus: an overlooked relationship in some regions","volume":"8","author":"Alhazmi","year":"2020","journal-title":"Microorganisms"},{"key":"2026010823414273700_B4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41574-022-00688-1","article-title":"Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus","volume":"18","author":"Nekoua","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"2026010823414273700_B5","doi-asserted-by":"publisher","first-page":"2300253","DOI":"10.2807\/1560-7917.ES.2023.28.22.2300253","article-title":"Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023","volume":"28","author":"Grapin","year":"2023","journal-title":"Euro Surveill"},{"key":"2026010823414273700_B6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3201\/eid3002.231024","article-title":"Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023","volume":"30","author":"Chau","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"2026010823414273700_B7","doi-asserted-by":"publisher","first-page":"e29194","DOI":"10.1002\/jmv.29194","article-title":"First description and phylogenetic analysis of coxsackie virus A non-polio enteroviruses and parechoviruses A in South Sudanese children","volume":"95","author":"Coudere","year":"2023","journal-title":"J Med Virol"},{"key":"2026010823414273700_B8","article-title":"About Non-Polio Enteroviruses","year":"2024"},{"key":"2026010823414273700_B9","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.apsb.2021.08.017","article-title":"Enterovirus A71 antivirals: past, present, and future","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"2026010823414273700_B10","doi-asserted-by":"publisher","first-page":"e2406","DOI":"10.1002\/rmv.2406","article-title":"Combating coxsackievirus B infections","volume":"33","author":"Alhazmi","year":"2023","journal-title":"Rev Med Virol"},{"key":"2026010823414273700_B11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jare.2023.03.007","article-title":"Advances in anti-EV-A71 drug development research","volume":"56","author":"Wang","year":"2024","journal-title":"J Adv Res"},{"key":"2026010823414273700_B12","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/ph17091218","article-title":"From the \u201cOne-Molecule, One-Target, One-Disease\u201d Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) Infections","volume":"17","author":"Roux","year":"2024","journal-title":"Pharmaceuticals"},{"key":"2026010823414273700_B13","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/v17091178","article-title":"Antiviral strategies targeting enteroviruses: current advances and future directions","volume":"7","author":"Lee","year":"2025","journal-title":"Viruses"},{"key":"2026010823414273700_B14","doi-asserted-by":"publisher","first-page":"106079","DOI":"10.1016\/j.antiviral.2025.106079","article-title":"Seeking innovative concepts in development of antiviral drug combinations","volume":"234","author":"Kainov","year":"2025","journal-title":"Antiviral Res"},{"key":"2026010823414273700_B15","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/v12101178","article-title":"Identification and tracking of antiviral drug combinations","volume":"12","author":"Ianevski","year":"2020","journal-title":"Viruses"},{"key":"2026010823414273700_B16","doi-asserted-by":"publisher","first-page":"e0334721","DOI":"10.1128\/mbio.03347-21","article-title":"Drug combinations as a first line of defense against coronaviruses and other emerging viruses","volume":"12","author":"White","year":"2021","journal-title":"mBio"},{"key":"2026010823414273700_B17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00018-025-05581-4","article-title":"Synergistic combination of orally available safe-in-man pleconaril, AG7404, and mindeudesivir inhibits enterovirus infections in human cell and organoid cultures","volume":"82","author":"Ravlo","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"2026010823414273700_B18","doi-asserted-by":"publisher","first-page":"105842","DOI":"10.1016\/j.antiviral.2024.105842","article-title":"The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants","volume":"224","author":"Ianevski","year":"2024","journal-title":"Antiviral Res"},{"key":"2026010823414273700_B19","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3390\/v14091866","article-title":"Novel synergistic anti-enteroviral drug combinations","volume":"14","author":"Ianevski","year":"2022","journal-title":"Viruses"},{"key":"2026010823414273700_B20","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM197905243002102","article-title":"Isolation of a virus from the pancreas of a child with diabetic ketoacidosis","volume":"300","author":"Yoon","year":"1979","journal-title":"N Engl J Med"},{"key":"2026010823414273700_B21","doi-asserted-by":"publisher","first-page":"10080","DOI":"10.1038\/s41598-019-46227-3","article-title":"Impact of coxsackievirus-B4E2 combined with a single low dose of streptozotocin on pancreas of outbred mice: investigation of viral load, pathology and inflammation","volume":"9","author":"Benkahla","year":"2019","journal-title":"Sci Rep"},{"key":"2026010823414273700_B22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jviromet.2005.05.005","article-title":"Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression","volume":"128","author":"Biacchesi","year":"2005","journal-title":"J Virol Methods"},{"key":"2026010823414273700_B23","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1093\/bioinformatics\/btaa138","article-title":"Breeze: an integrated quality control and data analysis application for high-throughput drug screening","volume":"36","author":"Potdar","year":"2020","journal-title":"Bioinformatics"},{"key":"2026010823414273700_B24","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1038\/srep05193","article-title":"Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies","volume":"4","author":"Yadav","year":"2014","journal-title":"Sci Rep"},{"key":"2026010823414273700_B25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/cancers14030525","article-title":"Pancreatic cancer organoids in the field of precision medicine: a review of literature and experience on drug sensitivity testing with multiple readouts and synergy scoring","volume":"14","author":"Makinen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026010823414273700_B26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"2026010823414273700_B27","doi-asserted-by":"publisher","first-page":"102725","DOI":"10.1016\/j.xpro.2023.102725","article-title":"Protocol for generating embedding-free brain organoids enriched with oligodendrocytes","volume":"4","author":"Al-Mhanawi","year":"2023","journal-title":"STAR Protoc"},{"key":"2026010823414273700_B28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.reth.2021.12.003","article-title":"Addition of Chk1 inhibitor and BMP4 cooperatively promotes retinal tissue formation in self-organizing human pluripotent stem cell differentiation culture","volume":"19","author":"Yamasaki","year":"2022","journal-title":"Regen Ther"},{"key":"2026010823414273700_B29","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","article-title":"Cardioids reveal self-organizing principles of human cardiogenesis","volume":"184","author":"Hofbauer","year":"2021","journal-title":"Cell"},{"key":"2026010823414273700_B30","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2026010823414273700_B31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12859-021-04294-2","article-title":"HAVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences","volume":"22","author":"Truong\u00a0Nguyen","year":"2021","journal-title":"BMC Bioinf"},{"key":"2026010823414273700_B32","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"2026010823414273700_B33","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1093\/nar\/gks918","article-title":"LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets","volume":"40","author":"Wilm","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2026010823414273700_B34","doi-asserted-by":"publisher","first-page":"2463830","DOI":"10.1080\/20450885.2025.2463830","article-title":"Assessing patient risk, benefit, and outcomes in drug development: a decade of vemurafenib clinical trials","volume":"12","author":"Gardner","year":"2025","journal-title":"Melanoma Manag"},{"key":"2026010823414273700_B35","doi-asserted-by":"publisher","first-page":"e0055223","DOI":"10.1128\/spectrum.00552-23","article-title":"Vemurafenib inhibits acute and chronic enterovirus infection by affecting cellular kinase phosphatidylinositol 4-kinase type IIIbeta","volume":"11","author":"Laajala","year":"2023","journal-title":"Microbiol Spectr"},{"key":"2026010823414273700_B36","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3390\/ph15091067","article-title":"Vemurafenib inhibits enterovirus A71 genome replication and virus assembly","volume":"15","author":"Hu","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026010823414273700_B37","doi-asserted-by":"publisher","first-page":"e1007962","DOI":"10.1371\/journal.ppat.1007962","article-title":"Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites","volume":"15","author":"Horova","year":"2019","journal-title":"PLoS Pathog"},{"key":"2026010823414273700_B38","doi-asserted-by":"publisher","first-page":"e00068","DOI":"10.1128\/mSphere.00068-16","article-title":"Mutations in Encephalomyocarditis Virus 3A protein uncouple the dependency of genome replication on host factors phosphatidylinositol 4-kinase iiialpha and oxysterol-binding protein","volume":"1","author":"Dorobantu","year":"2016","journal-title":"mSphere"},{"key":"2026010823414273700_B39","doi-asserted-by":"publisher","first-page":"ftaa065","DOI":"10.1093\/femspd\/ftaa065","article-title":"Effect of consecutive alternating administration of a triple combination of anti-enteroviral compounds in mice infected with coxsackievirus B3","volume":"78","author":"Stoyanova","year":"2020","journal-title":"Pathog Dis"},{"key":"2026010823414273700_B40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4149\/av_2021_410","article-title":"Effects of double combinations of enterovirus replication inhibitors against Coxsackie B viruses","volume":"65","author":"Stoyanova","year":"2021","journal-title":"Acta Virol"},{"key":"2026010823414273700_B41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/microorganisms13010199","article-title":"In vivo and in vitro studies assessing the antiviral efficacy of double combinations against coxsackievirus B infection","volume":"13","author":"Stoyanova","year":"2025","journal-title":"Microorganisms"},{"key":"2026010823414273700_B42","doi-asserted-by":"publisher","first-page":"W272","DOI":"10.1093\/nar\/gkac348","article-title":"DrugVirus.info 2.0: an integrative data portal for broad-spectrum antivirals (BSA) and BSA-containing drug combinations (BCCs)","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2026010823414273700_B43","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s12250-021-00404-9","article-title":"Cucurbit[7]uril as a broad-spectrum antiviral agent against diverse RNA viruses","volume":"36","author":"Quan","year":"2021","journal-title":"Virol Sin"},{"key":"2026010823414273700_B44","doi-asserted-by":"publisher","first-page":"e0049121","DOI":"10.1128\/AAC.00491-21","article-title":"Nodosome inhibition as a novel broad-spectrum antiviral strategy against arboviruses, enteroviruses, and SARS-CoV-2","volume":"65","author":"Limonta","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2026010823414273700_B45","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3389\/fmicb.2020.01105","article-title":"Remdesivir (GS-5734) impedes enterovirus replication through viral RNA synthesis inhibition","volume":"11","author":"Ye","year":"2020","journal-title":"Front Microbiol"},{"key":"2026010823414273700_B46","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijid.2020.02.018","article-title":"Discovery and development of safe-in-man broad-spectrum antiviral agents","volume":"93","author":"Andersen","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2026010823414273700_B47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/v11100964","article-title":"Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine","volume":"13","author":"Andersen","year":"2019","journal-title":"Viruses"},{"key":"2026010823414273700_B48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.antiviral.2018.04.007","article-title":"Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system","volume":"154","author":"Jiang","year":"2018","journal-title":"Antiviral Res"},{"key":"2026010823414273700_B49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2018.04.016","article-title":"Novel activities of safe-in-human broad-spectrum antiviral agents","volume":"154","author":"Ianevski","year":"2018","journal-title":"Antiviral Res"},{"key":"2026010823414273700_B50","first-page":"64","article-title":"Interferon-alpha and inosine pranobex-mediated inhibition of reploication of human RNA viruses in vitro","volume":"68","author":"Majewska","year":"2016","journal-title":"Med Dosw Mikrobiol"},{"key":"2026010823414273700_B51","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1128\/AAC.03328-14","article-title":"The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication","volume":"58","author":"Tijsma","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026010823414273700_B52","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/med.21292","article-title":"Molecular biology and inhibitors of hepatitis A virus","volume":"34","author":"Debing","year":"2014","journal-title":"Med Res Rev"},{"key":"2026010823414273700_B53","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1128\/AAC.02084-12","article-title":"Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C","volume":"57","author":"Ulferts","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026010823414273700_B54","doi-asserted-by":"publisher","first-page":"e742","DOI":"10.1038\/cddis.2013.267","article-title":"Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice","volume":"4","author":"Kakkola","year":"2013","journal-title":"Cell Death Dis"},{"key":"2026010823414273700_B55","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1086\/527326","article-title":"Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication","volume":"197","author":"Li","year":"2008","journal-title":"J Infect Dis"},{"key":"2026010823414273700_B56","first-page":"326","article-title":"[Synthesis and antiviral activity of hydrazides and substituted benzalhydrazides of betulinic acid and its derivatives]","volume":"29","author":"Flekhter","year":"2003","journal-title":"Bioorg Khim"},{"key":"2026010823414273700_B57","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2026010823414273700_B58","first-page":"323","article-title":"Methisoprinol-effect on the replication cycle of human hepatitis A virus","volume":"15","author":"Divizia","year":"1992","journal-title":"Microbiologica"},{"key":"2026010823414273700_B59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1128\/AAC.36.1.100","article-title":"In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity","volume":"36","author":"Andries","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"2026010823414273700_B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2015.10.011","article-title":"Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses","volume":"124","author":"Kang","year":"2015","journal-title":"Antiviral Res"},{"key":"2026010823414273700_B61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.antiviral.2014.10.009","article-title":"An adenosine nucleoside analogue NITD008 inhibits EV71 proliferation","volume":"112","author":"Shang","year":"2014","journal-title":"Antiviral Res"},{"key":"2026010823414273700_B62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.antiviral.2017.01.002","article-title":"Inhibition of enterovirus 71 replication by an alpha-hydroxy-nitrile derivative NK-1.9k","volume":"141","author":"Wang","year":"2017","journal-title":"Antiviral Res"},{"key":"2026010823414273700_B63","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1128\/AAC.01073-16","article-title":"In vitro assessment of combinations of enterovirus inhibitors against enterovirus 71","volume":"60","author":"Wang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026010823414273700_B64","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1038\/s41591-023-02576-1","article-title":"Pleconaril and ribavirin in new-onset Type 1 diabetes: a phase 2 randomized trial","volume":"29","author":"Krogvold","year":"2023","journal-title":"Nat Med"}],"container-title":["NAR Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/narmolmed\/advance-article-pdf\/doi\/10.1093\/narmme\/ugaf046\/66115845\/ugaf046.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/narmolmed\/article-pdf\/3\/1\/ugaf046\/66115845\/ugaf046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/narmolmed\/article-pdf\/3\/1\/ugaf046\/66115845\/ugaf046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T04:41:48Z","timestamp":1767933708000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/narmolmed\/article\/doi\/10.1093\/narmme\/ugaf046\/8402829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/narmme\/ugaf046","relation":{},"ISSN":["2976-856X"],"issn-type":[{"value":"2976-856X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,23]]},"article-number":"ugaf046"}}